National trial evaluates Therapeutic Plasma Exchange in septic shock patients

Septic shock, a life-threatening infection, is among the most common reasons for admission to ICUs in Manitoba and is a leading cause of death. Septic shock leads to uncontrolled inflammation and coagulation abnormalities. Apart from antibiotics and supportive care, there are few treatments available. Cancer patients are at higher risk of infections and septic shock due to immunosuppression from the underlying disease and chemotherapy.

Accessible molecular testing contributing to better outcomes for Manitobans

Molecular testing has become more accessible for Manitobans living with cancer after physicians saw its importance in providing patients with the best possible treatment, based on their genetic profile. CCMB researchers conducted a study to test the effectiveness of a new class of medications, PARP inhibitors, in treating metastatic castrate-resistant prostate cancer patients with alterations within BRCA and ATM genes. …